International faculty and attendees have gathered annually to educate, learn and receive updates of the latest innovations in diagnosis and management for Adult Congenital Heart Disease.
Tackling & Transforming Outcomes of Complex ACHD is the theme of this year's Symposium. Number and complexity of ACHD patients are rapidly increasing, and the medical community is facing new challenges in this unique population.
Congenital heart disease is a
lifespan disease, with different aspect during the journey of our patients, and this aspect – from infancy to adulthood – will be featured in some sessions.
We will cover lesion-specific complications and challenges regarding management, but we will also address tough end of life questions, frequently addressed to late or even neglected.
Toronto, with its very long and strong history in congenital heart disease (CHD), is the home of thousands of pediatric and adult CHD patients. It has built on its tradition and legacy on excellence in patient care, education and research. The Toronto faculty will report about the Toronto experiences and lessons learnt from patients with heart failure, and with transposition of the great arteries, with a special focus as a lifespan disease.
This year's Symposium presents
new and special features:
topics amongst others will be discussed:
I expect the Symposium to provide the best of science and education in this area of practice. The Program is designed for all healthcare professionals working with Adult Congenital Heart Disease and should familiarize participants with the latest clinical information on the diagnosis and management for ACHD. Nurses and Cardiac Care Associates also have a major organizational and educational role within this Program.
Welcome to Toronto!
Erwin Oechslin, MD FRCPCDirector of the Symposium